ARCHIVES

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

This article is from The Cancer Letter archive.

Vol. 35 No. 34 | September 18, 2009

Download PDF Visit The Full Archive

Related Articles

New ESA Label Maintains 12 g/dL

November 9, 2007

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

FDA Committee to Discuss Policy On Combinations

January 7, 1977

NCI Approved CTEP Trials For the Month of August

August 31, 2012

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989